Schmidt & Clark, LLP | A National Law Firm

Avandia® Recall Lawsuit


|


Avandia RecallThe U.S. Food & Drug Adminsitration (FDA) is currently reviewing the safety data of Avandia and related studies in order to determine whether an Avandia recall will be issued.

*** Avandia® Labeling Update 2/4/11: The FDA has notified healthcare professionals and patients that information on the cardiovascular risks (including heart attack) of Avandia (rosiglitazone) has been added to the physician labeling and patient Medication Guide. Additionally, the drug labels have been revised to state that rosiglitazone and rosiglitazone-containing medicines should only be used:

  • In patients already being treated with these medicines
  • In patients whose blood sugar cannot be controlled with other anti-diabetic medicines and who, after consulting with their healthcare professional, do not wish to use pioglitazone-containing medicines (Actos, Actoplus Met, Actoplus Met XR, or Duetact).

Do I Have an Avandia Lawsuit?

As of this time, an Avandia recall has not been issued, however our law firm is continuing to accept Avandia side effect cases in all 50 states. If you or a loved one has suffered a heart attack, stroke or other serious side effect after taking Avandia, you should contact our law firm immediately. You may be entitled to compensation by filing an Avandia lawsuit and we can help.

Related Content on our Website

Attention Attorneys:  Schmidt & Clark considers a referral from another law firm to be one of the greatest compliments. Our law firm has built a reputation for success and accepts a number of case referrals on a regular basis. We do not publish prior verdicts or settlements on our website. If you would like to refer us a case or for us to send you a profile of prior award judgments or average referral fees, please visit the attorney referral section of our website.